ArriVent BioPharma, Inc. (NASDAQ:AVBP – Get Free Report)’s stock price dropped 8.3% during trading on Tuesday . The stock traded as low as $20.36 and last traded at $20.60. Approximately 119,302 shares were traded during trading, a decline of 26% from the average daily volume of 161,620 shares. The stock had previously closed at $22.47. […]
(Bloomberg) Kyverna Therapeutics Inc. raised $319 million in a US initial public offering priced above a marketed range, as drug developers continue to receive a warm welcome from new investors.Most Read from BloombergCitadel Among Hedge Funds That Got Morgan Stanley’s Block-Trading LeaksTesla Asks Which Jobs Are Critical, Stoking Layoff FearsChina Replaces Top Markets Regulator as Xi Tries to End RoutUS Commercial Real Estate Contagion Is Now Moving to EuropeHaley Loses Nevada Primary to ‘No
Week In Review: Arrivent BioPharma Raises $175M In IPO For In-Licensings From China seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.